Have a personal or library account? Click to login
International survey of neuromuscular monitoring in two European countries: a questionnaire study among Hungarian and Romanian anaesthesiologists Cover

International survey of neuromuscular monitoring in two European countries: a questionnaire study among Hungarian and Romanian anaesthesiologists

Open Access
|Jun 2019

References

  1. 1. Murphy GS, Szokol JW, Marymont JH, Greenberg SB, Avram MJ, Vender JS. Residual neuromuscular blockade and critical respiratory events in the postanesthesia care unit. Anesth Analg 2008; 107: 130-137. doi: 10.1213/ane.0b013e31816d126810.1213/ane.0b013e31816d126818635478
  2. 2. Berg H, Roed J, Viby-Mogensen J, Mortensen CR, Engbaek J, Skovgaard LT, et al. Residual neuromuscular block is a risk factor for postoperative pulmonary complications. A prospective, randomised, and blinded study of postoperative pulmonary complications after atracurium, vecuronium and pancuronium. Acta Anaesthesiol Scand 1997; 41: 1095-1103. doi: 10.1111/j.1399-6576.1997.tb04851.x10.1111/j.1399-6576.1997.tb04851.x9366929
  3. 3. Ledowski T, Hillyard S, O’Dea B, Archer R, Vilas-Boas F, Kyle B. Introduction of sugammadex as standard reversal agent: Impact on the incidence of residual neuromuscular blockade and postoperative patient outcome. Indian J Anaesth 2013; 57: 46-51. doi: 10.4103/0019-5049.1085622371676610.4103/0019-5049.108562365833523716766
  4. 4. Arbous MS, Meursing AE, van Kleef JW, de Lange JJ, Spoormans HH, Touw P, et al. Impact of anesthesia management characteristics on severe morbidity and mortality. Anesthesiology 2005; 102: 257-26810.1097/00000542-200502000-0000515681938
  5. 5. Grosse-Sundrup M, Henneman JP, Sandberg WS, Bateman BT, Uribe JV, Nguyen NT, et al. Intermediate acting non-depolarizing neuromuscular blocking agents and risk of postoperative respiratory complications: prospective propensity score matched cohort study. BMJ 2012; 345: e6329. doi: 10.1136/bmj.e632910.1136/bmj.e6329347308823077290
  6. 6. Fortier LP, McKeen D, Turner K, de Médicis É, Warriner B, Jones PM, et al. The RECITE Study: A Canadian Prospective, Multicenter Study of the Incidence and Severity of Residual Neuromuscular Blockade. Anesth Analg 2015; 121: 366-372. doi: 10.1213/ANE.000000000000075710.1213/ANE.000000000000075725902322
  7. 7. Kopman AF, Yee PS, Neuman GG. Relationship of the train of-four fade ratio to clinical signs and symptoms of residual paralysis in awake volunteers. Anesthesiology 1997; 86: 765-771. doi: 10.1097/00000542-199704000-0000510.1097/00000542-199704000-000059105219
  8. 8. Cammu G, De Witte J, De Veylder J, Byttebier G, Vandeput D, Foubert L, et al. Postoperative residual paralysis in outpatients versus inpatients. Anesth Analg 2006; 102: 426-429. doi: 10.1213/01.ane.0000195543.61123.1f16428537
  9. 9. Kotake Y, Ochiai R, Suzuki T, Ogawa S, Takagi S, Ozaki M, et al. Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscular block. Anesth Analg 2013; 117: 345-351. doi: 10.1213/ANE.0b013e318299967210.1213/ANE.0b013e318299967223757472
  10. 10. Nemes R, Fülesdi B, Pongrácz A, Asztalos L, Szabó-Maák Z, Lengyel S, et al. Impact of reversal strategies on the incidence of postoperative residual paralysis after rocuronium relaxation without neuromuscular monitoring: A partially randomised placebo controlled trial. Eur J Anaesthesiol 2017; 34: 609-616. doi: 10.1097/EJA.000000000000058510.1097/EJA.000000000000058528030444
  11. 11. Sasaki N, Meyer MJ, Malviya SA, Stanislaus AB, MacDonald T, Doran ME, et al. Effects of neostigmine reversal of nondepolarizing neuromuscular blocking agents on postoperative respiratory outcomes: a prospective study. Anesthesiology 2014; 121: 959-968. doi: 10.1097/ALN.000000000000044010.1097/ALN.000000000000044025225821
  12. 12. Naguib M, Kopman AF, Ensor JE. Neuromuscular monitoring and postoperative residual curarisation: a meta-analysis. Br J Anaesth 2007; 98: 302-316. doi: 10.1093/bja/ael38610.1093/bja/ael38617307778
  13. 13. Cammu GV, Smet V, De Jongh K, Vandeput D. A prospective, observational study comparing postoperative residual curarisation and early adverse respiratory events in patients reversed with neostigmine or sugammadex or after apparent spontaneous recovery. Anaesth Intensive Care 2012; 40: 999-1006. doi: 10.1177/0310057X120400061110.1177/0310057X120400061123194209
  14. 14. Murphy GS, Szokol JW, Marymont JH, Greenberg SB, Avram MJ, Vender JS, et al. Intraoperative acceleromyographic monitoring reduces the risk of residual neuromuscular blockade and adverse respiratory events in the postanesthesia care unit. Anesthesiology 2008; 109: 389-398. doi: 10.1097/ALN.0b013e318182af3b10.1097/ALN.0b013e318182af3b18719436
  15. 15. Brueckmann B, Sasaki N, Grobara P, Li MK, Woo T, de Bie J, et al. Effects of sugammadex on incidence of postoperative residual neuromuscular blockade: a randomized, controlled study. Br J Anaesth 2015; 115: 743-751. doi: 10.1093/bja/aev10410.1093/bja/aev10425935840
  16. 16. Murphy GS, Szokol JW, Avram MJ, Greenberg SB, Marymont JH, Vender JS, et al. Intraoperative acceleromyography monitoring reduces symptoms of muscle weakness and improves quality of recovery in the early postoperative period. Anesthesiology 2011; 115: 946-954. doi: 10.1097/ALN.0b013e318234284010.1097/ALN.0b013e318234284021946094
  17. 17. Naguib M, Kopman AF, Lien CA, Hunter JM, Lopez A, Brull SJ. A survey of current management of neuromuscular block in the United States and Europe. Anesth Analg 2010; 111: 110-119. doi: 10.1213/ANE.0b013e3181c0742810.1213/ANE.0b013e3181c0742819910616
  18. 18. Della Rocca G, Iannuccelli F, Pompei L, Pietropaoli P, Reale C, Di Marco P. Neuromuscular block in Italy: a survey of current management. Minerva Anestesiol 2012; 78: 767-773
  19. 19. Phillips S, Stewart PA, Bilgin AB. A survey of the management of neuromuscular blockade monitoring in Australia and New Zealand. Anaesth Intensive Care 2013; 41: 374-379. doi: 10.1177/0310057X130410031610.1177/0310057X130410031623659401
  20. 20. Beecher HK, Todd DP. A study of the deaths associated with anesthesia and surgery: based on a study of 599,548 anesthesias in ten institutions 1948-1952, inclusive. Ann Surg 1954; 140: 2-35. doi: 10.1097/00000658-195407000-0000110.1097/00000658-195407000-00001160960013159140
  21. 21. Ali HH, Kitz RJ. Evaluation of recovery from nondepolarizing neuromuscular block, using a digital neuromuscular transmission analyzer: preliminary report. Anesth Analg 1973; 52: 740-745
  22. 22. Sundman E, Witt H, Olsson R, Ekberg O, Kuylenstierna R, Eriksson LI. The incidence and mechanisms of pharyngeal and upper esophageal dysfunction in partially paralyzed humans. Pharyngeal videoradiography and simultaneous manometry after atracurium. Anesthesiology 2000; 92: 977-984.10.1097/00000542-200004000-0001410754616
  23. 23. Tassonyi E. A new concept in the measurement of neuromuscular transmission and block. Anaesthesist 1975; 24: 374-377
  24. 24. Waud BE, Waud DR. The relation between tetanic fade and receptor occlusion in the presence of competitive neuromuscular block. Anesthesiology 1971; 35: 456-46410.1097/00000542-197111000-000034329144
  25. 25. Capron F, Alla F, Hottier C, Meistelman C, Fuchs-Buder T. Can acceleromyography detect low levels of residual paralysis? A probability approach to detect a mechanomyographic train-of-four ratio of 0.9. Anesthesiology 2004; 100: 1119-1124. doi: 10.1097/00000542-200405000-0001310.1097/00000542-200405000-0001315114208
  26. 26. Viby-Mogensen J, Jensen NH, Engbaek J, Ørding H, Skovgaard LT, Chraemmer-Jørgensen B. Tactile and visual evaluation of the response to train-of-four nerve stimulation. Anesthesiology 1985; 63: 440-443. doi: 10.1097/00000542-198510000-0001510.1097/00000542-198510000-000154037404
  27. 27. Eikermann M, Groeben H, Hüsing J, Peters J. Accelerometry of adductor pollicis muscle predicts recovery of respiratory function from neuromuscular blockade. Anesthesiology 2003; 98: 1333-1337. doi: 10.1097/00000542-200306000-0000610.1097/00000542-200306000-0000612766640
  28. 28. Plaud B, Debaene B, Donati F, Marty J. Residual paralysis after emergence from anesthesia. Anesthesiology 2010; 112: 1013-1022. doi: 10.1097/ALN.0b013e3181cded0710.1097/ALN.0b013e3181cded0720234315
  29. 29. Checketts MR, Alladi R, Ferguson K, Gemmell L, Handy JM, Klein AA, et al. Recommendations for standards of monitoring during anaesthesia and recovery 2015: Association of Anaesthetists of Great Britain and Ireland. Anaesthesia 2016; 71: 85-93. doi: 10.1111/anae.1331610.1111/anae.13316506318226582586
  30. 30. Brull SJ, Kopman AF. Current Status of Neuromuscular Reversal and Monitoring: Challenges and Opportunities. Anesthesiology 2017; 126: 173-190. doi: 10.1097/ALN.000000000000140910.1097/ALN.000000000000140927820709
  31. 31. Naguib M, Brull SJ, Kopman AF, Hunter JM, Fülesdi B, Arkes HR, et al. Consensus Statement on Perioperative Use of Neuromuscular Monitoring. Anesth Analg 2018; 127: 71-80. doi: 10.1213/ANE.000000000000267010.1213/ANE.000000000000267029200077
  32. 32. Herbstreit F, Zigrahn D, Ochterbeck C, Peters J, Eikermann M. Neostigmine/glycopyrrolate administered after recovery from neuromuscular block increases upper airway collapsibility by decreasing genioglossus muscle activity in response to negative pharyngeal pressure. Anesthesiology 2010; 113: 1280-1288. doi: 10.1097/ALN.0b013e3181f70f3d10.1097/ALN.0b013e3181f70f3d20980910
DOI: https://doi.org/10.2478/rjaic-2019-0007 | Journal eISSN: 2502-0307 | Journal ISSN: 2392-7518
Language: English
Page range: 45 - 51
Submitted on: Feb 14, 2019
Accepted on: Mar 30, 2019
Published on: Jun 18, 2019
Published by: Sciendo
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year

© 2019 Adrienn Pongrácz, Réka Nemes, Caius Breazu, László Asztalos, Ileana Mitre, Edömér Tassonyi, Béla Fülesdi, Calin Mitre, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.